본문 바로가기

Impact of cytokines on diffuse splenic F-18-fluorodeoxyglucose uptake during positron emission tomography/computed tomography

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
NUCLEAR MEDICINE COMMUNICATIONS34(1) · pp.64 · 2013
피인용
Web of Science 25
JCR IF
JCR 2012 1.379
ISSN
0143-3636

저자

  1. 박경준제1저자Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
  2. 김성장교신저자Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
  3. 김인주Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
  4. 김동욱ADepartment of Internal Medicine, Medical Research Institute, Pusan National University Hospital, South Korea
  5. 김근영Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea
  6. 김희영Department of Nuclear Medicine, BioMedical Research Institute, Pusan National University Hospital, South Korea

초록

Objectives Concurrent inflammation or anemia at the time of PET/computed tomography (CT) could be one of several causes of diffuse splenic F-18-fluorodeoxyglucose (F-18-FDG) uptake. In this study, we focused on cytokines to investigate interactions during this phenomenon and clarify the significance of splenic F-18-FDG uptake in PET/CT. Methods We selected 40 patients (17 women and 23 men) with cholangiocarcinoma, pancreatic cancer, or gallbladder cancer who had undergone PET/CT. These patients were subdivided into two groups (group A: patients showing splenic F-18-FDG uptake exceeding hepatic uptake; group B: patients showing hepatic F-18-FDG uptake exceeding splenic uptake). Blood sampling was performed for each patient on the same day as PET/CT, and 22 types of cytokines and hematologic indices were analyzed. Results Group A showed higher levels of interleukin (IL)-1 beta (P=0.0478), IL-1RA (P=0.0044), IL-4 (P=0.0118), IL-6 (P=0.0375), IL-7 (P=0.0478), and IL-13 (P=0.0081) compared with group B. However, interferon-inducible protein-10 (IP-10; P=0.1714), IL-9 (P=0.8022), IL-8 (P=0.1631), IL-5 (P=0.5273), IL-3 (P=0.3097), IL-23 (P=0.1194), IL-2 (P=0.1099), IL-1 alpha (P=0.4439), IL-17 alpha (P=0.8811), IL-16 (P=0.3201), IL-15 (P=0.0580), interferon-gamma (IFN-gamma; P=0.5308), growth-regulated oncogene (GRO; P=0.2847), granulocyte macrophage-colony-stimulating factor (GM-CSF; P=0.0913), granulocyte-colony-stimulating factor (G-CSF; P=0.5244), and soluble CD40 ligand (sCD40L; P=0.1714) levels in group A were not statistically significantly different compared with those in the control group. In addition, the white blood cell counts and C-reactive protein levels in group A showed higher values compared with group B. IL-13 among the cytokines and C-reactive protein among the hematologic indices were significant predictors of splenic F-18-FDG uptake exceeding hepatic F-18-FDG uptake. Conclusion This study showed that splenic F-18-FDG uptake is related to IL-1 beta, IL-1 receptor antagonist, IL-4, IL-6, IL-7, and IL-13. These cytokines may reflect the activation of humoral immunity of the spleen. Nucl Med Commun 34:64-70 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins. Nuclear Medicine Communications 2013, 34:64-70

키워드

cytokinesF-18-fluorodeoxyglucosepositron emission tomography and computed tomographyspleenGROWTH-FACTORFDG-PETINTERLEUKIN-6PATHOGENESISINFECTIONPROTEINDISEASECANCER

식별자

WoS UID
000312512300011